Skip to main content

Cannabis and cannabinoids preclinical pharmacology

  1. Cannabis contains Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) as the primary constituents responsible for pharmacological activity. However, there are numerous additional chemically-related structures ...

    Authors: Alykhan Devsi, Brett Kiyota, Theophile Ouellette, Andrew P. Hegle, Ricardo E. Rivera-Acevedo, Jasper Wong, Ying Dong, Michael K. Pugsley and Timothy Fung

    Citation: Journal of Cannabis Research 2020 2:17

    Content type: Original research

    Published on:

  2. Substantial advancements were achieved in the management of postoperative pain, however the need for further improvement remains. This study explores the pharmacokinetics and safety of the CannaHaler, a metere...

    Authors: Offir Ben-Ishay, Ortal Bar-On and Yoram Kluger

    Citation: Journal of Cannabis Research 2020 2:15

    Content type: Original research

    Published on:

  3. Chronic obstructive pulmonary disease (COPD) is commonly associated with both a pro-inflammatory and a T-helper 1 (Th1) immune response. It was hypothesized that cannabis oil extract can alleviate COPD symptom...

    Authors: Stephen W. Mamber, Volkan Gurel, Jeremy Lins, Fred Ferri, Sarah Beseme and John McMichael

    Citation: Journal of Cannabis Research 2020 2:5

    Content type: Original research

    Published on: